Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

October 8, 2007

Abbotts ABT-874 shows good results in Psoriasis

Analysis of: Abbott's ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study | www.pipelinereview.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Analysis By:
Sunil Dhawan, MD, Clinical Assistant Professor of DermatologySunil Dhawan, MD
Clinical Assistant Professor of Dermatology, Stanford University
Implications: Abbotts ABT-874 monoclonal antibody for psoriasis shows impressive results in the phase 2 trial. The results were up to 90% of patients achieving at least 75% reduction in their psoriasis. These results are as good or better than those with Remicade the most effective biologic for psoriasis currently. Side effects were not discussed. The Centocor product has similar efficacy and it will be  tight race to determinre the winner.

Analysis: Once these products are released the other current products will have a hard time competing with either Abbotts or Centocors products in term of efficacy. The only thing holding them up would be unforeseen side effects.

Other Analyses of the Same Source Article:
A new race in Psoriasis
October 5, 2007, Author: GLG Expert Contributor

Report a Concern

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-03T09:45:16.743